Works matching IS 01418955 AND DT 2017 AND VI 40 AND IP 4


Results: 15
    1
    2
    3
    4

    Molecular therapy of primary hyperoxaluria.

    Published in:
    Journal of Inherited Metabolic Disease, 2017, v. 40, n. 4, p. 481, doi. 10.1007/s10545-017-0045-3
    By:
    • Martin-Higueras, Cristina;
    • Torres, Armando;
    • Salido, Eduardo
    Publication type:
    Article
    5

    What is new in CDG?

    Published in:
    Journal of Inherited Metabolic Disease, 2017, v. 40, n. 4, p. 569, doi. 10.1007/s10545-017-0050-6
    By:
    • Jaeken, Jaak;
    • Péanne, Romain
    Publication type:
    Article
    6
    7
    8

    High-content drug screening for rare diseases.

    Published in:
    Journal of Inherited Metabolic Disease, 2017, v. 40, n. 4, p. 601, doi. 10.1007/s10545-017-0055-1
    By:
    • Bellomo, F.;
    • Medina, D.;
    • De Leo, E.;
    • Panarella, A.;
    • Emma, F.
    Publication type:
    Article
    9
    10
    11

    Cysteamine revisited: repair of arginine to cysteine mutations.

    Published in:
    Journal of Inherited Metabolic Disease, 2017, v. 40, n. 4, p. 555, doi. 10.1007/s10545-017-0060-4
    By:
    • Gallego-Villar, L.;
    • Hannibal, L.;
    • Häberle, J.;
    • Thöny, B.;
    • Ben-Omran, T.;
    • Nasrallah, G.;
    • Dewik, Al-N.;
    • Kruger, W.;
    • Blom, H.
    Publication type:
    Article
    12
    13

    Amino acid synthesis deficiencies.

    Published in:
    Journal of Inherited Metabolic Disease, 2017, v. 40, n. 4, p. 609, doi. 10.1007/s10545-017-0063-1
    By:
    • Koning, T.
    Publication type:
    Article
    14
    15